SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

A sharp, apparently newsless XCN spike is driving attention, with traders debating whether it is a fleeting pump-and-dump or a rebound worth buying. Some point to Bitcoin turning green and bullish chart patterns, while others cite XCNs history of quick spikes followed by drops.

Papa John's International, Inc. engages in the operation and franchise of pizza delivery and carryout restaurants. It operates through the following segments: Domestic Company-owned Restaurants, North America Franchising, North America Commissaries, International Operations, and All Others. The Domestic Company-Owned Restaurants segment consists of retail sales of pizza and side items, breadsticks, cheese sticks, chicken poppers and wings, dessert items, and canned and bottled beverages. The North America Franchising segment involves the offering of sales and support activities, development rights, and collection of royalties from franchisees located in the United States and Canada. The North America Commissaries segment includes the eleven full-service regional dough production and distribution and quality control centers. The International Operations segment represents all restaurant operations outside of the United States and Canada. The All Others segment focuses on franchise contributions to marketing funds and sale, company-owned and franchised restaurants, information systems and related services used in restaurant operations, point-of-sale system, online and other technology-based ordering platforms, printing, and promotional items. The company was founded by John H. Schnatter in 1984 and is headquartered in Louisville, KY.

Papa John`s International, Inc.

Attention centers on reports that Papa Johns largest U.S. franchisee has joined Irth Capitals effort to take the company private. Traders are hopeful a deal could materialize, but uncertainty over the boards response and whether the bid will close remains a point of debate.

MaxLinear, Inc. engages in the provision of communications systems-on-chip (SoC) solutions used in broadband, mobile and wireline infrastructure, data center, and industrial and multi-market applications. Its products include cable broadband modems and gateways, wireline connectivity devices, radio frequency transceivers, fiber-optic modules, video set-top boxes and gateways, hybrid analog and digital televisions, direct broadcast satellite outdoor and indoor units, and power management and interface products. The company was founded by Kimihiko Imura, Curtis C. Ling, and Kishore V. Seendripu on September 25, 2003 and is headquartered in Carlsbad, CA.

MaxLinear Inc

A beat-and-raise quarterly report and a third increase to MaxLinears 2026 optical data-center outlook are reinforcing its AI optics growth story. Traders are divided as the shares fall despite the strong update, citing higher expectations, cash-flow concerns, and competition in high-speed interconnects.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Phase 3 results showing IMDELLTRA plus Imfinzi reduced the risk of death in first-line extensive-stage small-cell lung cancer are driving discussion, with traders viewing the data as a potential growth catalyst for Amgens oncology business. Some also point to Repathas growth as support for the companys broader portfolio.

Global X Funds - Global X Dow 30 Covered Call ETF

Global X Dow 30 Covered Call ETF

Discussion centers on volatile Dow and broader-market moves amid rising Treasury yields, hawkish Fed concerns, and oil and geopolitical risks tied to Iran. Traders are divided between warnings of a deeper selloff and bullish calls for a rebound, with some noting the Dows relative strength versus tech-heavy indexes.

Permian Resources Corp. is an oil and natural gas company, which focuses on returns to stakeholders through the responsible acquisition, optimization and development of crude oil and associated liquids-rich natural gas reserves. The company was founded on December 18, 2025 and is headquartered in Midland, TX.

Permian Resources Holdings Inc. - Ordinary Shares - Class A

Permian Resources Corp - Ordinary Shares - Class A

Permian Resources is drawing attention amid volatile oil prices and Middle East supply concerns, especially disruptions and uncertainty around the Strait of Hormuz and Iran negotiations. Bulls see elevated crude and the companys production growth as supportive, while skeptics point to peace-deal headlines, inventory concerns, and the stocks uneven response to oil moves.

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Agenus Inc

Agenuss BOT+BAL colorectal cancer results are driving discussion, with traders highlighting tumor responses and the possibility of organ preservation while questioning whether small, nonrandomized studies will translate into durable benefit. Optimism about the treatments potential is tempered by concerns over Phase 3 timing, dilution, and management execution.

FMC Corp. is an agricultural sciences company, which engages in the provision of solutions to growers and development of pipeline in crop protection, plant health, agriculture, pest control, and turf management. It offers insect control products under the Rynaxypyr and Cyazypyr brands. The company was founded by John Bean in 1883 and is headquartered in Philadelphia, PA.

FMC Corp.

FMCs sharp outlook reset, driven by price cuts on distributor-held inventory and weak demand, is fueling concern about its business outlook and debt burden. Traders are split between fears of further financial distress and the view that the inventory reset and debt-reduction efforts could support a longer-term turnaround.

United Airlines Holdings, Inc. is a holding company, which engages in the provision of transportation services. It operates through the following geographical segments: Domestic, Atlantic, Pacific, and Latin America. The company was founded on December 30, 1968 and is headquartered in Chicago, IL.

United Airlines Holdings Inc

Uniteds quarterly results and weaker-than-expected profit outlook have focused attention on rising jet-fuel costs and pressure on margins, despite strong revenue and travel demand. Traders are split between concern over the guidance and optimism that resilient bookings and a recent share-price rebound may offset the bad news.

Six Flags Entertainment Corp. engages in operating amusement parks in North America. It operates amusement parks, water parks, and resorts. The company is headquartered in Charlotte, NC.

Six Flags Entertainment Corp.

Six Flags Entertainment Corp

Shares are under pressure amid fallout from a fatal accident on Six Flags Goliath coaster, with traders concerned about ride closures, the safety investigation, potential lawsuits and reputational damage. The discussion also centers on heavy debt and bearish analyst views, while some traders argue the selloff and high short interest could set up a rebound.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Curis, Inc. Announces Pricing of $8.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules with Existing Healthcare Focused Institutional Investors

Curis, Inc. Announces Pricing of $8.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules with Existing Healthcare Focused Institutional Investors Curis, Inc. Announces Pricing of $8.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules with Existing Healthcare Focused...

Curis, Inc. Announces Pricing of $5.6 Million Public Offering

Curis, Inc. Announces Pricing of $5.6 Million Public Offering Curis, Inc. Announces Pricing of $5.6 Million Public Offering PR Newswire LEXINGTON, Mass., Aug. 13, 2026 LEXINGTON, Mass., Aug. 13, 2026 /PRNewswire/ -- Curis, Inc. (Nasdaq: CRIS), a biotechnology company focused on the development of...

Curis Doses First Five Patients in TakeAim CLL Study

Curis Doses First Five Patients in TakeAim CLL Study Curis Doses First Five Patients in TakeAim CLL Study PR Newswire LEXINGTON, Mass., July 30, 2026 LEXINGTON, Mass., July 30, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib...

Curis Gains As Blood Cancer Drug Progresses, December Readout in Focus

Curis gained attention after positive emavusertib data as analyst raised its price target to $43 and highlighted upcoming trial catalysts.read more...

Curis Strengthens Oncology Pipeline Outlook With Strong TakeAim Lymphoma Response Rates

Curis shares positive updated clinical data for emavusertib and increases its year-end guidance for the TakeAim CLL study.read more...

Curis Announces Positive Emavusertib Update

Curis Announces Positive Emavusertib Update Curis Announces Positive Emavusertib Update PR Newswire LEXINGTON, Mass., July 22, 2026 Updated Clinical Data in PCNSLIncreased Guidance on Year-End Data in CLLCompany to Host Webcast at 8:30 a.m. ETLEXINGTON, Mass., July 22, 2026 /PRNewswire/ -- Curis...

Why Q32 Bio Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket

Gainers: Q32 Bio up 29.6%, Mint up 75.8%, Fast Track up 58.2%, eLong up 33.4%, Sobr Safe up 29.2%, Eshallgo up 20.3%, Curis up 10.9%, Sky Quarry up 10.6%, Accuray up 9.5%, Bitzero up 5.5%. Losers: Global Mofy down 25.3%, Jiuzi down 22.1%, Julong down 21.4%, Haoxi down 20.4%, Sadot down 20.4%.read...

Curis Consents First Six Patients in TakeAim CLL Study

Curis Consents First Six Patients in TakeAim CLL Study Curis Consents First Six Patients in TakeAim CLL Study PR Newswire LEXINGTON, Mass., July 6, 2026 LEXINGTON, Mass., July 6, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib...

Why Did Curis (CRIS) Stock Soar After Hours?

Curis, Inc. shares surged 8.51% after the bell after the company confirmed its approved reverse stock split will take effect on Thursday.read more...

12 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers

Curis (NASDAQ:CRIS) stock rose 9.0% to $0.46 during Wednesday's after-market session. The company's market cap stands at $20.3 million.
Humacyte (NASDAQ:HUMA) shares moved upwards by 5.45% to $0.71.read more...

Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170 and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.

Curis Inc

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$0.3863
Prev Close	$0.4049
Open	$0.4064
Dividend Yield	0.00%
50-Day Moving Average	$1.05
Beta	1.18
Avg. Volume	154,404.50
PE Ratio	-0.03

52-Week High	$33.00
52-Week Low	$0.325
Market Capitalization	$807,397.00
EPS (Annual)	-$11.52
Price to Book	0.16
Revenue Per Employee	$393,458.33

Feed

News

Sentiment

Earnings

Fundamentals

Info

CRIS Fundamentals